Treatment of Low-Renin Essential Hypertension
- 4 February 1974
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 227 (5), 518-521
- https://doi.org/10.1001/jama.1974.03230180016005
Abstract
Seventeen patients with low-renin essential hypertension were studied in a double-blind comparison of the antihypertensive effect of spironolactone with that of a hydrochlorothiazide-triamterene combination. All 17 patients responded to spironolactone. The decrease in average mean blood pressure was 20.7 mm Hg accompanied by an average diuresis of —3.1 kg. Fourteen of the 17 patients had favorable responses to hydrochlorothiazide-triamterene. The average decrease in mean blood pressure was 17.0 mm Hg, and the average diuresis was —1.5 kg. The difference in mean blood pressure response was not statistically significant. The fact that both forms of therapy were effective, even though their mechanisms of action differ, suggests that extracellular fluid volume reduction may be the key factor in the amelioration of hypertension in patients with "low-renin essential hypertension."Keywords
This publication has 4 references indexed in Scilit:
- Low Renin Hypertension and the Adrenal CortexNew England Journal of Medicine, 1972
- Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid ExcessAnnals of Internal Medicine, 1971
- Effect of Spironolactone in Hypertensive PatientsThe American Journal of the Medical Sciences, 1970
- Salivary Sodium-Potassium Ratio and Plasma Renin Activity in HypertensionCirculation, 1969